ESGAB breakpoint determination: clarithromycin.
Phillips
I
I
Acar
J
J
Baquero
F
F
Bergan
T
T
Forsgren
A
A
Wiedemann
B
B
D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D017291:Clarithromycin; D004917:Erythromycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D009177:Mycoplasma pneumoniae / Q000187:drug effects
D004917:Erythromycin; D017291:Clarithromycin